Got news to share with the events industry?
Submit a press release or story tip and reach thousands of event professionals.
Get in touch→More in Health Tech
BioSpace
Details from Novartis’ failed cardiovascular trial offer ‘little silver lining’ for rivals
BioSpace
With an approval apiece, the verdict is still out on AbbVie’s and BMS’ twin neuro buys
BioSpace
FDA orders class-wide GLP-1 label update to include potential risk for rare eye disease
STAT News
STAT+: Pharmalittle: We’re reading about a Novartis heart drug, BIO fighting a Trump program, and more
STAT News
STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke
BioSpace
Vir's hepatitis delta combo tamps down virus as Gilead showdown looms
Related Insights
Workforce transformation and the future of skillsThe Time Paradox: Why Being Busy Doesn't Mean You're Moving Forward - The Foundations of Lasting Success Week 1
Busy calendars can hide stalled progress. Reclaim your attention, protect priorities, and make time for future growth.
13 min read
Clean energy and grid modernizationThe Grid Gamble: How Electricity Could Decide the Next Industrial Superpower
China is building more than power stations and transmission lines. It is developing an electricity system designed to support AI, advanced manufacturing, electric vehicles, renewable energy, and future industries. The ambition is enormous, but so are the engineering and economic challenges.
15 min read
AI infrastructureInside the Cloud, Part 2: The AI Gold Rush Has a Plumbing Problem — and That's Just the Beginning
The expansion of artificial intelligence is creating a much larger industrial economy than most people realize. Behind the computers are energy producers, mining companies, engineers, skilled tradespeople, security specialists, and investors.
20 min read